Sfoglia per AUTORE
BERRUTI A
Collezione AO Cuneo

  

Items : 9

Effectiveness of a phone-based nurse monitoring assessment and intervention for chemotherapy-related toxicity: A randomized multicenter trial. in Frontiers in oncology / Front Oncol. 2022 Sep 15;12:925366. doi: 10.3389/fonc.2022.925366. eCollection 2022.

2022
AO Ordine Mauriziano
AO Cuneo
ASL Cuneo 1
AOU Alessandria

Mariani G; Di Pede P; Spinelli GP; Santini D; Zustovich F; Bossi P; Di Maio M; Numico G; Gunnellini M; Rossi M; Giordano M; Corsi DC; Fabi A; Berruti A; Coletta D; Sbrana A; Galli L; Miccinesi G; Velutti L; Sammarco E; Roila F; Antonuzzo A; Ripamonti CI;

Maintenance versus discontinuation of androgen deprivation therapy during continuous or intermittent docetaxel administration in castration-resistant prostate cancer patients: A multicentre, randomised Phase III study by the Piemonte Oncology Network. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 Sep;155:127-135. doi: 10.1016/j.ejca.2021.06.034. Epub 2021 Aug 6.

2021
AO Cuneo
ASL Asti
ASL Biella
ASL Cuneo 2
AOU Città della Salute di Torino
ASL Città di Torino
AOU Novara

Tucci M; Baier S; Gennari A; Bellissimo AR; Ciccone G; Masini C; Sacco C; Amoroso D; Montagnani F; Comandone A; Ortega C; Buttigliero C; Fea E; Vanella P; Valcamonico F; Zamparini M; Sirotova Z; Chiappino I; Bianchi S; Mosca A; Dalla Volta A; Prati V; Dal Canton O; Berruti A;

First-line pazopanib in patients with advanced non-clear cell renal carcinoma: An Italian case series. in World journal of clinical oncology / World J Clin Oncol. 2021 Nov 24;12(11):1037-1046. doi: 10.5306/wjco.v12.i11.1037.

2021
AO Cuneo

Petrelli F; Naglieri E; Fea E; Berruti A; Fornarini G; Facchini G; Procopio G; Boccardo F; Galli L; Caserta C; Carteni G; Basso U; Aurilio G; Caffo O; De Giorgi U; Massari F; Bersanelli M; Buti S; Iacovelli R; Porta C; Mosca A;

Maintenance versus discontinuation of androgen deprivation therapy during docetaxel administration with a continuous or an intermittent schedule in metastatic, castration resistant, prostate cancer patients: A multicenter randomized phase III study of the Piemonte Oncology Network in Annals of Oncology

2020
ASL Biella
ASL Città di Torino
ASL Asti
AO Cuneo
ASL Cuneo 2
AOU Città della Salute di Torino

Fea E; Buttigliero C; Montagnani F; Comandone A; Gennari A; Tucci M; Chiappino I; Canton OD; Masini C; Sacco† C; Amoroso D; Sirotova Z; Ciccone G; Valcamonico F; Vanella P; Ortega C; Prati V; Bianchi S; Mosca A; Berruti A;

Bone metastases from head and neck malignancies: Prognostic factors and skeletal-related events. in PloS one / PLoS One. 2019 Mar 20;14(3):e0213934. doi: 10.1371/journal.pone.0213934. eCollection 2019.

2019
AOU Città della Salute di Torino
AO Cuneo

Berruti A; Resteghini C; Magrini SM; Maroldi R; Nicolai P; Tonoli S; Pronzato P; Alfieri S; Ibrahim T; Rossetto C; Carlini P; Merlano M; Conte P; Airoldi M; Bergamini C; Vecchio S; Bonetta A; Triggiani L; Locati LD; Bianchi S; Grisanti S;

Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2016 Jun;102:47-54. doi: 10.1016/j.critrevonc.2016.03.012. Epub 2016 Mar 11.

2016
AO Cuneo

Magrini SM; Murphy B; Russi EG; Raber-Durlacher J; Barasch A; Nicolai P; Trippa F; Berruti A; Gastaldi G; Majorana A; Bossi P; Orlandi E; Salgarello S; Grisanti S; Vassalli L; Maddalo M; Di Rosario F; Cavagnini R; Buglione M;

Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Dental pathologies and osteoradionecrosis (Part 1) literature review and consensus statement. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2016 Jan;97:131-42. doi: 10.1016/j.critrevonc.2015.08.010. Epub 2015 Aug 12.

2016
AO Cuneo

Magrini SM; Murphy B; Raber-Durlacher J; Barasch A; Russi EG; Maroldi R; Nicolai P; Pavanato G; Berruti A; Bossi P; Gastaldi G; Majorana A; Paganelli C; Orlandi E; Salgarello S; Grisanti S; Vassalli L; Maddalo M; Sottocornola L; Di Rosario F; Cavagnini R; Buglione M;

Real-world study of everolimus in advanced progressive neuroendocrine tumors. in The oncologist / Oncologist. 2014 Sep;19(9):966-74. doi: 10.1634/theoncologist.2014-0037. Epub 2014 Aug 12.

2014
AOU San Luigi di Orbassano
AO Cuneo

Delle Fave G; Falconi M; Colao A; Berruti A; Appetecchia M; Cartenì G; Campana D; Cassano A; Ambrosio MR; Fontana A; Pusceddu S; Spada F; Funaioli C; Antonuzzo L; Chiara S; Merlano M; Cascinu S; Pastorelli D; Faggiano A; Nobili E; Zaniboni A; Brizzi MP; Nuzzo C; Riccardi F; Tomassetti P; Lugli F; Zatelli MC; Luppi G; de Braud F; et alii...

Prognostic factors in metastatic breast cancer patients obtaining objective response or disease stabilization after first-line chemotherapy with epirubicin. Evidence for a positive effect of maintenance hormonal therapy on overall survival in Anticancer Research

1997
ASL Cuneo 1
ASL Biella
ASL Cuneo 2
AO Cuneo

Berruti A; Zola P; Buniva T; Baú MG; Farris A; Sarobba MG; Bottin A; Tampellini M; Durando A; Destefanis M; Monzeglio C; Moro G; Sussio M; Perroni D; Dogliotti L;